Pharma BD Deal Intelligence
Novartis AG / GlaxoSmithKline plc
2014 · Asset Purchase · $16.0B · Complete
Announcement Sentiment
88
Strongly positive
Outcome Score
81
Worked — the deal delivered on its rationale.
Novartis acquired GSK's oncology portfolio for $16B as part of the 2014 three-part asset swap between GSK and Novartis.
Key facts
- Announced Apr 22, 2014
- Closed Mar 02, 2015
- Deal value $16.0B
- Deal type Asset Purchase
- Therapeutic area Oncology
See the full interactive analysis, sources & comparables →
← Browse all deals ·
How we score deals